Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,334 | -6,246 | -4,902 | -1,438 | -7,060 |
| Accounts payable and accrued liabilities | 243 | -528 | -996 | -580 | -973 |
| Other Working Capital | 2,439 | 2,306 | 997 | 1,498 | -4,941 |
| Other Operating Activity | 2,294 | 2,833 | 3,558 | 603 | 1,677 |
| Operating Cash Flow | $-3,358 | $-1,635 | $-1,343 | $83 | $-11,297 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -380 | -177 | N/A | N/A | N/A |
| Other Investing Activity | -500 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-880 | $-177 | $0 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 22,112 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 1,291 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $23,403 |
| Exchange Rate Effect | -97 | -6 | -41 | -48 | 40 |
| Beginning Cash Position | 12,574 | 12,574 | 12,574 | 12,574 | 427 |
| End Cash Position | 8,238 | 10,756 | 11,191 | 12,609 | 12,574 |
| Net Cash Flow | $-4,335 | $-1,818 | $-1,383 | $35 | $12,146 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,358 | -1,635 | -1,343 | 83 | -11,297 |
| Capital Expenditure | -380 | -177 | N/A | N/A | N/A |
| Free Cash Flow | -3,738 | -1,812 | -1,343 | 83 | -11,297 |